Aug 13, 2024
1:5
For every 5 shares held, investors received 1.
The split itself did not change the total investment value.
Monopar Therapeutics Inc. (GETTEX:1IY0) operates in the Biotechnology industry.
Monopar Therapeutics Inc. company overviewMonopar Therapeutics Inc.'s most recent stock split was on August 13, 2024. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.
Monopar Therapeutics Inc. has split its stock once. This history records one reverse split, on August 13, 2024.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Monopar Therapeutics Inc.'s 1-for-5 reverse split on August 13, 2024, every 5 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Monopar Therapeutics Inc. has not announced a new split in our records. Its most recent split was on August 13, 2024, 2 years ago. Companies announce splits in advance, and any new GETTEX:1IY0 split will appear on this page.